ConductScience.org, home

Paper36969867

Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges?

Chen S and 3 others. Front Pharmacol, 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges? Papers, record 36969867. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969867

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges?
PubMed
Journal
Front Pharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
4.08
iCite
Revised in PubMed
2023-03-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen SSiqian
2Wang JJiayi
3Feng JJiating
4Xuan RRongrong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135056816Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications.Molecules2022https://conductscience.org/library/papers/35056816PubMed
231470537Sublingual Delivery of Astaxanthin through a Novel Ascorbyl Palmitate-Based Nanoemulsion: Preliminary Data.Mar Drugs2019https://conductscience.org/library/papers/31470537PubMed
323590613Physico-chemical stability of astaxanthin nanodispersions prepared with polysaccharides as stabilizing agents.Int J Food Sci Nutr2013https://conductscience.org/library/papers/23590613PubMed
430172200Astaxanthin-alpha tocopherol nanoemulsion formulation by emulsification methods: Investigation on anticancer, wound healing, and antibacterial effects.Colloids Surf B Biointerfaces2018https://conductscience.org/library/papers/30172200PubMed
533155666Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review).Int J Mol Med2021https://conductscience.org/library/papers/33155666PubMed
634636497Multi-Mechanistic Antidiabetic Potential of Astaxanthin: An Update on Preclinical and Clinical Evidence.Mol Nutr Food Res2021https://conductscience.org/library/papers/34636497PubMed
731251469Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models.IUBMB Life2019https://conductscience.org/library/papers/31251469PubMed
827428953Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity.Int J Mol Sci2016https://conductscience.org/library/papers/27428953PubMed
933761600Nrf2 a molecular therapeutic target for Astaxanthin.Biomed Pharmacother2021https://conductscience.org/library/papers/33761600PubMed
1032784629Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer.Mar Drugs2020https://conductscience.org/library/papers/32784629PubMed
1135406135Astaxanthin Bioactivity Is Determined by Stereoisomer Composition and Extraction Method.Nutrients2022https://conductscience.org/library/papers/35406135PubMed
1232937179Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy.Eur J Pharm Biopharm2020https://conductscience.org/library/papers/32937179PubMed
1333277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1434286807Preparation and characterization of glycosylated protein nanoparticles for astaxanthin mitochondria targeting delivery.Food Funct2021https://conductscience.org/library/papers/34286807PubMed
1531619957Receptor-Mediated Delivery of Astaxanthin-Loaded Nanoparticles to Neurons: An Enhanced Potential for Subarachnoid Hemorrhage Treatment.Front Neurosci2019https://conductscience.org/library/papers/31619957PubMed
1634677433Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control.Mar Drugs2021https://conductscience.org/library/papers/34677433PubMed
1735423427Cytotoxicity of targeted PLGA nanoparticles: a systematic review.RSC Adv2021https://conductscience.org/library/papers/35423427PubMed
1834126176Preparation of astaxanthin micelles self-assembled by a mechanochemical method from hydroxypropyl β-cyclodextrin and glyceryl monostearate with enhanced antioxidant activity.Int J Pharm2021https://conductscience.org/library/papers/34126176PubMed
1912727382Haematococcus astaxanthin: applications for human health and nutrition.Trends Biotechnol2003https://conductscience.org/library/papers/12727382PubMed
2030380797Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure.Molecules2018https://conductscience.org/library/papers/30380797PubMed

See all 56 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42382501Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review.Health Sci Rep2026https://conductscience.org/library/papers/42382501PubMed
42310631
Hepatorenal protective and antitumor effects of astaxanthin-loaded chitosan nanoparticles against ehrlich ascites carcinoma in mice through antioxidant, anti-inflammatory, and apoptotic pathway modulation.
BMC Cancer2026https://conductscience.org/library/papers/42310631PubMed
42198217Astaxanthin Delivery Across Administration Routes: Recent Advances to Improve Stability and Bioavailability.Pharmaceutics2026https://conductscience.org/library/papers/42198217PubMed
41978098Synergistic Effects of a Pro-Inflammatory-High-Fat Composite Dietary Pattern on Gut-Liver Injury and the Therapeutic Potential of Haematococcus pluvialis-Derived Astaxanthin.Nutrients2026https://conductscience.org/library/papers/41978098PubMed
41599661Innovations in the Delivery of Bioactive Compounds for Cancer Prevention and Therapy: Advances, Challenges, and Future Perspectives.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599661PubMed
41404045Biological function of astaxanthin and its application in aquatic animal feeding.Food Chem X2025https://conductscience.org/library/papers/41404045PubMed
41155474Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.Int J Mol Sci2025https://conductscience.org/library/papers/41155474PubMed
39698514Intranasal delivery of macrophage cell membrane cloaked biomimetic drug-nanoparticle system attenuates acute lung injury.J Tissue Eng2024https://conductscience.org/library/papers/39698514PubMed
39475763The senomorphic impact of astaxanthin on irradiated rat spleen: STING, TLR4 and mTOR contributed pathway.Int J Immunopathol Pharmacol2024https://conductscience.org/library/papers/39475763PubMed
39061947Recent Advances in Astaxanthin as an Antioxidant in Food Applications.Antioxidants (Basel)2024https://conductscience.org/library/papers/39061947PubMed
38794332A Review of Recent Developments in Biopolymer Nano-Based Drug Delivery Systems with Antioxidative Properties: Insights into the Last Five Years.Pharmaceutics2024https://conductscience.org/library/papers/38794332PubMed
38132951The Clinical Promise of Microalgae in Rheumatoid Arthritis: From Natural Compounds to Recombinant Therapeutics.Mar Drugs2023https://conductscience.org/library/papers/38132951PubMed
37998337Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies?Cells2023https://conductscience.org/library/papers/37998337PubMed
37888465Extraction and Purification of Highly Active Astaxanthin from Corynebacterium glutamicum Fermentation Broth.Mar Drugs2023https://conductscience.org/library/papers/37888465PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36969867

GET https://conductscience.org/api/papers/v1/36969867/references?page=2